Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 181,677 |
|
|||||
| News | - | ||||||
| Day High | 2.485 | Low High |
|||||
| Day Low | 2.27 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Regulus Therapeutics Inc | RGLS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.135 | 5.95% | 2.405 | 14:22:50 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.30 | 2.27 | 2.485 | 2.27 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,478 | 181,677 | $ 2.41 | $ 437,755 | - | 1.08 - 3.78 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 14:32:29 | 1 | $ 2.4009 | USD |
Regulus Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 49.55M | 20.22M | - | 0 | -30.04M | -1.49 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Regulus Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RGLS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.23 | 2.485 | 2.09 | 2.20 | 128,190 | 0.175 | 7.85% |
| 1 Month | 2.90 | 2.91 | 2.09 | 2.61 | 315,821 | -0.495 | -17.07% |
| 3 Months | 1.32 | 3.78 | 1.2724 | 2.38 | 3,326,889 | 1.09 | 82.20% |
| 6 Months | 1.31 | 3.78 | 1.08 | 2.37 | 1,557,189 | 1.10 | 83.59% |
| 1 Year | 1.39 | 3.78 | 1.08 | 2.35 | 788,523 | 1.02 | 73.02% |
| 3 Years | 1.40 | 3.78 | 0.1576 | 1.10 | 1,124,965 | 1.01 | 71.79% |
| 5 Years | 1.12 | 3.78 | 0.1576 | 1.17 | 1,186,692 | 1.29 | 114.73% |
Regulus Therapeutics Description
| Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. MicroRNA is a noncoding ribonucleic acid that regulates most genes in the genome. The company partnered with Sanofi to create a compound targeting orphan diseases and with AstraZeneca to cure Type 2 Diabetes/prediabetes. |
